A kind of traditional Chinese medicine composition for treating polycystic ovary syndrome

Abstract

The invention relates to a traditional Chinese medicine composition used for treating polycystic ovarian syndrome. The traditional Chinese medicine composition can effectively solve the medicine use problem of polycystic ovarian syndrome. According to the technical scheme, the traditional Chinese medicine composition is composed of 22 grams to 26 grams of prepared rehmannia roots, 13 grams to 17 grams of herba epimedii, 27 grams to 33 grams of semen cuscutae, 13 grams to 17 grams of atractylodes macrocephala, 13 grams to 17 grams of poria cocos, 8 grams to 12 grams of pericarpium citri reticulatae, 7 grams to 11 grams of ginger processed pinellia, 5 grams to 7 grams of rhizoma cyperi, 13 grams to 17 grams of medicinal cyathula roots, 27 grams to 33 grams of salviae miltiorrhizae and 8 grams to 12 grams of semen brassicae. The raw materials are abundant, scientific in component and reasonable in medicine compatibility and support one another, the traditional Chinese medicine composition is effective medicine for treating polycystic ovarian syndrome, has the effects of warming kidneys, tonifying spleens, reducing phlegm, removing blood stasis, regulating the menstruation and assisting in reproduction, is effectively used for treating polycystic ovarian syndrome, is good in curative effect, safe in medicine use, free of toxic and side effects, stable in curative effect, safe, reliable and innovative.

Description

technical field [0001] The invention relates to medicine, in particular to a traditional Chinese medicine composition for treating polycystic ovary syndrome. Background technique [0002] Polycystic ovary syndrome (PCOS) is a common endocrine syndrome in women of reproductive age. In 1935, Stein and Leventhal first described bilateral ovarian enlargement with infertility, hirsutism and obesity, which was called Stein-Leventhal syndrome. With the deepening of clinical research, the scope of clinical syndromes with polycystic ovary with anovulation and / or hirsutism on histology is expanding. In 1963, Goldziether summarized 187 articles with a total of 1079 cases of PCOS data, and found that there were many atypical cases, such as no hirsutism, and even ovulation. With the development of detection technology, it is recognized that polycystic ovary is not a unique disease, but a clinical syndrome with multiple etiologies and extremely heterogeneous presentation. At present, m...

AI Technical Summary

Problems solved by technology

At present, most of the drugs for the treatment of polycystic ovary syndrome are western medicines, which have large side effects and treat the symptoms but not the root cause. Chinese medicine has a history of thousands of years, has accumulated rich medical knowledge, and is unique in the treatment of diseases. Therefore, to provide a treatment Traditional Chinese medicine for polycystic ovary syndrome is imperative